Literature DB >> 19306226

Invasion of the alveolar-capillary barrier by Aspergillus spp.: therapeutic and diagnostic implications for immunocompromised patients with invasive pulmonary aspergillosis.

William W Hope1.   

Abstract

Aspergillus spp. are leading causes of morbidity and mortality in immunocompromised patients. This review provides an overview of host defenses, the mechanisms by which the alveolar-capillary barrier is breeched by Aspergillus, and the implications for diagnosis and treatment of patients with invasive pulmonary aspergillosis.

Entities:  

Mesh：

Year:  2009        PMID： 19306226     DOI： 10.1080/13693780802510232

Source DB:  PubMed          Journal:  Med Mycol        ISSN： 1369-3786            Impact factor:   4.076


  10 in total

1.  New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis.

Authors:  Christophe Duret; Nathalie Wauthoz; Thami Sebti; Francis Vanderbist; Karim Amighi
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

2.  Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis.

Authors:  Jodi M Lestner; Susan J Howard; Joanne Goodwin; Lea Gregson; Jayesh Majithiya; Thomas J Walsh; Gerard M Jensen; William W Hope
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

3.  The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.

Authors:  William W Hope; Vidmantas Petraitis; Ruta Petraitiene; Tamarra Aghamolla; John Bacher; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

4.  Aspergillus fumigatus allergen expression is coordinately regulated in response to hydrogen peroxide and cyclic AMP.

Authors:  Marcin G Fraczek; Rifat Rashid; Marian Denson; David W Denning; Paul Bowyer
Journal:  Clin Mol Allergy       Date:  2010-11-03

5.  The temporal dynamics of differential gene expression in Aspergillus fumigatus interacting with human immature dendritic cells in vitro.

Authors:  Charles O Morton; John J Varga; Anke Hornbach; Markus Mezger; Helga Sennefelder; Susanne Kneitz; Oliver Kurzai; Sven Krappmann; Hermann Einsele; William C Nierman; Thomas R Rogers; Juergen Loeffler
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

6.  Requirement of a putative mitochondrial GTPase, GemA, for azole susceptibility, virulence, and cell wall integrity in Aspergillus fumigatus.

Authors:  Xiaogang Zhou; Guorong Yang; Chengxi Li; Fan Yang; Xuelian Chang
Journal:  Front Microbiol       Date:  2022-08-09       Impact factor: 6.064

7.  New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis.

Authors:  Christophe Duret; Nathalie Wauthoz; Thami Sebti; Francis Vanderbist; Karim Amighi
Journal:  Int J Nanomedicine       Date:  2012-10-18

8.  Gene expression profiles of human dendritic cells interacting with Aspergillus fumigatus in a bilayer model of the alveolar epithelium/endothelium interface.

Authors:  Charles Oliver Morton; Mirjam Fliesser; Marcus Dittrich; Tobias Mueller; Ruth Bauer; Susanne Kneitz; William Hope; Thomas Richard Rogers; Hermann Einsele; Juergen Loeffler
Journal:  PLoS One       Date:  2014-05-28       Impact factor: 3.240

9.  Hide, Keep Quiet, and Keep Low: Properties That Make Aspergillus fumigatus a Successful Lung Pathogen.

Authors:  Natalia Escobar; Soledad R Ordonez; Han A B Wösten; Pieter-Jan A Haas; Hans de Cock; Henk P Haagsman
Journal:  Front Microbiol       Date:  2016-04-06       Impact factor: 5.640

10.  A possible role for fumagillin in cellular damage during host infection by Aspergillus fumigatus.

Authors:  Xabier Guruceaga; Guillermo Ezpeleta; Emilio Mayayo; Monica Sueiro-Olivares; Ana Abad-Diaz-De-Cerio; José Manuel Aguirre Urízar; Hong G Liu; Philipp Wiemann; Jin Woo Bok; Scott G Filler; Nancy P Keller; Fernando L Hernando; Andoni Ramirez-Garcia; Aitor Rementeria
Journal:  Virulence       Date:  2018       Impact factor: 5.882
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.